- Milk Road
- Posts
- 🥛 What you missed this week 👀
🥛 What you missed this week 👀
Liberation Day, Circle's IPO & a deep-dive into $AERO
Today’s edition is brought to you by OKX – the centralized exchange that’s giving you the chance to win an iPhone 16, iPad Pro and more.

GM. This is Milk Road, the newsletter that’s back with another weekly roundup.
This past week, all eyes were on Trump’s “Liberation Day” - the day he slapped fresh tariffs on multiple countries.
Equities didn’t take the news well (they puked), but Bitcoin seems to be holding its ground.
Here’s everything else you might’ve missed this week. 👇️
WHAT YOU MISSED THIS WEEK
Are Trump’s tariffs…working? 🤨
The tariffs are definitely bringing some short-term pain - but we’ve broken down how they might just be laying the groundwork for long-term gain.
Circle is IPO-ing! 💲
This is just the beginning! With a more crypto-friendly SEC, we’re likely to see a wave of crypto IPOs this year.
But while it sounds bullish on the surface, Circle’s IPO filing has also sparked some big questions about its financials. 👇️
“The current macro set up is annoying” - Matt Hougan
You’d expect the CIO of Bitwise to be more profound in his findings but man, we completely agree with his sentiment.
Matt also dropped why he thinks this might be the best time ever to buy Bitcoin.
Check out the latest episode where the Bitwise Boys dive into macro, Bitcoin, and altcoins. Certified banger of an episode. Don’t miss it.
Watch or listen on:
YouTube | Spotify | Apple Podcasts
Introducing the Milk Road token snapshot 📸
You guys probably don’t know what this is (because it’s a brand new product!).
We’re launching a no-fluff format that breaks down tokens like never before:
What the token does
The bull & bear case for the token
What to watch out for
Because it’s our very first one (about $AERO), we’re making it free for everyone! But heads up, we’ll be dropping a bunch more in the coming months, and future ones will be PRO-only.
So, if you want direct access to multiple token insights, go PRO here.
Wanna earn some yield on your $ETH?
We’ve dropped a page laying out the best platforms to earn yield on your $ETH by lending it out.
If your $ETH is just sitting there, it might be time to put it to work. 👇️
Say goodbye to gas issues, multiple wallets and hassle of switching chains.
Whether you're trading or building on Ethereum, Solana, Aptos, or 30+ other chains, Okto is hiding the messy wires of Web3.
Yep, you read that right. You’ll have the chance to win all of those rewards when participating in OKX’s latest campaign.
Here’s how it works:
Register for the campaign here
Trade more than 150 $USDT to get a mystery box
Trade even more to unlock all of the rewards mentioned above
But don’t sleep on it – this campaign is only running through April. Once it’s gone, it’s gone.
So click below (before you forget) and lock in your chances to win! 👇

AUDIENCE FAVORITES 🥇
Our weekly roundup of our top content — decided by you! Featuring the most-opened newsletter, most-viewed podcast, and most-viral tweet.
NEWSLETTER: Top 5 revenue generating apps 📈
Money flows into companies that make actual revenue. That’s finance 101.
So we did the digging and rounded up the top revenue-generating crypto companies (with tokens) for March 2025.
PODCAST: The only indicator that matters right now in crypto 🎙️
Jesse Eckel comes on the pod to discuss how macro is currently in the driver’s seat and nothing else matter until this one indicator shifts.
Tune in below to understand what the indicator is and why it matters (Hint: we’ve been shouting this indicator on the newsletter as well).
Watch or listen on:
YouTube | Spotify | Apple Podcasts
TWEET:
And that’s a wrap on everything you might have missed this week. 🫡

MILKY MEMES OF THE WEEK 🤣

RATE TODAY’S EDITION
What'd you think of today's edition? |

DISCLAIMER: None of this is financial advice. This newsletter is strictly educational and is not investment advice or a solicitation to buy or sell any assets or to make any financial decisions. Please be careful and do your own research.
Reply